S. Peter Goedegebuure
- Oncology top 1%
- Immunology top 1%
- Molecular Biology top 10%
- Biomedical Engineering top 10%
- Cancer Research top 10%
- Co-authors
- David G. DeNardoDavid C. LinehanAndrea Wang‐GillamTimothy M. NyweningBrett L. KnolhoffMelissa A. MeyerJingqin LuoBrian L. West
- Topics
- Immunotherapy and Immune Responses (18 papers)Cancer Immunotherapy and Biomarkers (11 papers)Immune cells in cancer (8 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesNetherlandsQatar
In The Last Decade
S. Peter Goedegebuure
49 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 1.8k
- Immunology 1.7k
- Molecular Biology 746
- Biomedical Engineering 452
- Cancer Research 280
Countries citing papers authored by S. Peter Goedegebuure
This map shows the geographic impact of S. Peter Goedegebuure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Peter Goedegebuure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Peter Goedegebuure more than expected).
Fields of papers citing papers by S. Peter Goedegebuure
This network shows the impact of papers produced by S. Peter Goedegebuure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Peter Goedegebuure. The network helps show where S. Peter Goedegebuure may publish in the future.
Co-authorship network of co-authors of S. Peter Goedegebuure
This figure shows the co-authorship network connecting the top 25 collaborators of S. Peter Goedegebuure. A scholar is included among the top collaborators of S. Peter Goedegebuure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Peter Goedegebuure. S. Peter Goedegebuure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 64 | |
| 9 | 44 | |
| 10 | 4 | |
| 11 | 91 | |
| 12 | 55 | |
| 13 | 38 | |
| 14 | 7 | |
| 15 | 30 | |
| 16 | 179 | |
| 17 | 11 | |
| 18 | CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Modelsbreakdown → | 974 |
| 19 | 173 | |
| 20 | Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axisbreakdown → | 479 |
About S. Peter Goedegebuure
S. Peter Goedegebuure is a scholar working on Immunology, Oncology and Orthopedics and Sports Medicine, having authored 50 papers that have together received 2.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Immune cells in cancer (8 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (1.8k citations) and Cancer Research (280 citations). S. Peter Goedegebuure has collaborated with scholars based in United States, Netherlands and Qatar. Frequent co-authors include David G. DeNardo, David C. Linehan, Andrea Wang‐Gillam, Timothy M. Nywening, Brett L. Knolhoff, Melissa A. Meyer, Jingqin Luo, Brian L. West, Yu Zhu and Ryan C. Fields. Their work appears in journals such as JAMA, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.